6-氨基-2-苯并噻唑甲腈结构式
|
常用名 | 6-氨基-2-苯并噻唑甲腈 | 英文名 | 6-Amino-1,3-benzothiazole-2-carbonitrile |
---|---|---|---|---|
CAS号 | 7724-12-1 | 分子量 | 175.210 | |
密度 | 1.5±0.1 g/cm3 | 沸点 | 384.9±34.0 °C at 760 mmHg | |
分子式 | C8H5N3S | 熔点 | N/A | |
MSDS | 美版 | 闪点 | 186.6±25.7 °C | |
符号 |
GHS05, GHS07 |
信号词 | Danger |
中文名 | 6-氨基-2-苯并噻唑甲腈 |
---|---|
英文名 | 6-Amino-2-cyanobenzothiazole |
中文别名 | 6-氨基-2-苯并噻唑氰基 | 2-氰基-6-氨基苯并噻唑 | 6-氨基-2-氰基苯并噻唑 |
英文别名 | 更多 |
密度 | 1.5±0.1 g/cm3 |
---|---|
沸点 | 384.9±34.0 °C at 760 mmHg |
分子式 | C8H5N3S |
分子量 | 175.210 |
闪点 | 186.6±25.7 °C |
精确质量 | 175.020416 |
PSA | 90.94000 |
LogP | 0.96 |
蒸汽压 | 0.0±0.9 mmHg at 25°C |
折射率 | 1.736 |
储存条件 | 2-8°C |
符号 |
GHS05, GHS07 |
---|---|
信号词 | Danger |
危害声明 | H302-H318 |
警示性声明 | P280-P305 + P351 + P338 |
个人防护装备 | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
危害码 (欧洲) | Xi |
危险品运输编码 | NONH for all modes of transport |
海关编码 | 2934200090 |
~53% 6-氨基-2-苯并噻唑甲腈 7724-12-1 |
文献:The University of Tokyo Patent: US2007/155806 A1, 2007 ; Location in patent: Page/Page column 5 ; |
~% 6-氨基-2-苯并噻唑甲腈 7724-12-1 |
文献:US2011/213124 A1, ; |
~% 6-氨基-2-苯并噻唑甲腈 7724-12-1 |
文献:Chemistry - An Asian Journal, , vol. 6, # 7 p. 1800 - 1810 |
~% 6-氨基-2-苯并噻唑甲腈 7724-12-1 |
文献:Chemistry - An Asian Journal, , vol. 6, # 7 p. 1800 - 1810 |
~% 6-氨基-2-苯并噻唑甲腈 7724-12-1 |
文献:US2011/224442 A1, ; |
~% 6-氨基-2-苯并噻唑甲腈 7724-12-1 |
文献:US2011/224442 A1, ; |
~% 6-氨基-2-苯并噻唑甲腈 7724-12-1 |
文献:US2011/224442 A1, ; |
~% 6-氨基-2-苯并噻唑甲腈 7724-12-1 |
文献:US2011/224442 A1, ; |
海关编码 | 2934200090 |
---|---|
中文概述 | 2934200090. 其他含一个苯并噻唑环系的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
申报要素 | 品名, 成分含量, 用途 |
Summary | 2934200090. other compounds containing in the structure a benzothiazole ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Synthesis and characterization of a self-fluorescent hyaluronic acid-based gel for dermal applications.
Adv. Healthc. Mater. 4 , 2297-305, (2015) Combinations of polymer conjugates affording in situ gelation hold promise for treatment of pathological cavities (e.g., arthritis) and sustained drug release. In particular, hyaluronic acid (HA) func... |
2-Benzothiazolecarbonitrile, 6-amino- |
6-Amino-1,3-benzothiazole-2-carbonitrile |